TCR2 Therapeutics Inc. (Cambridge, Mass.) raised an untranched $125 million series B round on March 21 led by
TCR2 raises $125M series B
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
TCR2 Therapeutics Inc. (Cambridge, Mass.) raised an untranched $125 million series B round on March 21 led by